I am very interested in alternative therapies that can be used either stand alone or in conjunction with conventional therapies like chemotherapy. I found a paper in regards to AHCC that looked promising, but unfortunately has not reached mainstream. Many immune enhancers are natural compounds that have proved to be nontoxic for humans and with great potential for anticancer activity (Yin, Fujii, & Walshe, 2010). ACHH is active hexose correlated compound (AHCC), an extract prepared from mycelia of the basidiomycete mushroom Lentinula edodes. 74% of AHCC is oligosaccharides containing about 20% of the -1, 4-glucan type. It has received special attention in the past few years by its reported benefits. AHCC is commercially used as a nutritional supplement and contains a mixture of polysaccharides, amino acids, and minerals (Yin et al., 2010). Results of this particular study suggest that AHCC can enhance CD4 and CD8 T cell immune responses in healthy persons via increasing production of cytokines IFN-gamma and TNF-alpha from T cells. It has also been found that the effects of AHCC are more evident in hosts with the impaired immune function. The study measured the frequency of IFN-gamma and TNF-a producing CD4 and CD8 T cells in adults over age 50 before and after taking AHCC. The results were pretty interesting. AHCC was provided as 500-mg capsules. Total daily dose was 3 g (3 capsules twice daily). The production of the cytokines was measured at 30 and 60 days after AHCC intake and 30 days after the last dose. Interestingly, the frequency of CD4 T cell subsets producing the cytokines was higher at 30 and 60 days. Even after 30 days of discontinuing the AHCC, the frequency of CD4 T cells producing the combination of IFN-gamma and TNF-a at visit 4 was still higher compared to baseline levels. This implies that the effect of AHCC on CD4 T cells could last for several weeks even after this compound is discontinued (Yin et al., 2010)
Two published peer-reviewed human clinical studies (on 269 and 40 subjects respectively) evaluating advanced liver cancer showed extended survival, lower recurrence and improved quality of life among patients taking AHCC. Several other studies demonstrated the ability of AHCC to significantly increase NK cell activity in immune compromised patients. “Given the abundance of preliminary positive results across different infections, AHCC supplementation demonstrates valuable and clinically-relevant potential as an immune-enhancing compound” (Pescatore, n.d.). Finally, AHCC boasts a strong safety profile supported by a Phase I study conducted at Harvard, a 20-year history of use in Japan, its adoption by over 700 clinics and use by an estimated 70,000 people worldwide (including 20,000 in the U.S.). Thus, there is a strong case to be made for adding AHCC to a daily supplement regimen to support the body’s immune system, not only during the apparent times of increased infectious threat such as the flu season, but also all year long.
How can this help the population with bladder issues?
Theoretically, AHCC should be able to boost your natural immune system to defend you against pathogens that cause UTI’s. Both human and animal studies have pointed to AHCC’s ability to enhance the activity of natural killer cells (“NK cells”). These cells provide a crucial first defense for the body, launching a rapid attack while the other cells of the immune system are still mobilizing. AHCC has been the subject of several studies, which investigated its potential as a countermeasure to various infectious diseases, methicillin-resistant Staphylococcus aureus (MRSA) and several other opportunistic infections (Klebsiella pneumoniae, Candida albicans and Pseudomonas aeruginosa.) Looking at “opportunistic” or hospital-acquired infections, the effects of AHCC supplementation on the resistance to Klebsiella pneumoniae (principally associated with bacterial pneumonia and urinary tract infections) was studied in both infected and stress induced mice. Again, the AHCC-supplemented mice demonstrated increased survival, increased mean time until death, decreased susceptibility to infection and increased bacterial clearance from the blood.
Here is a link for the product on Amazon: https://amzn.to/2uaEVYN
Pescatore, F. (n.d.) AHCC a Powerful Aid in Fighting Viruses and Infections
Yin, Z., Fujii, H., & Walshe, T. (2010). Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum Immunol, 71(12), 1187-1190. doi:10.1016/j.humimm.2010.08.006
Want to try CBD? Click here for the link to order —>https://ichealer.primemybody.com/prod_FOCUS001
The areas I am going to focus on are Inflammation and the Immune System, Leaky Gut and Pain Management.
What is CBD anyway?
Believe it or not, your body produces endocannabinoids. The endocannabinoid receptors (ECS) are the biggest receptors in your body, and they exist in all higher life forms. The ECS has emerged as one of the key regulatory mechanisms in the brain controlling multiple events such as mood, pain perception, learning and memory among others. “It is also thought to provide a neuroprotective role during traumatic brain injury (TBI) and may be part of the brain’s natural compensatory repair mechanism during neurodegeneration.” (Kendall & Yudowski, 2016) We have two main receptors, CBD1 and CBD2. The CBD1 receptors are found primarily in the central nervous system, and CBD2 is found in immune cells. According to Gyires and Zadori, modulating the activity of the endocannabinoid system (ECS), which comprises CB1 and CB2 receptors, the endocannabinoids and their synthetic and metabolizing enzymes, may have therapeutic potential in numerous diseases including obesity/metabolic syndrome, diabetes, neuro- degenerative, inflammatory, cardiovascular and psychiatric disorders, liver and skin diseases, pain, cachexia, cancer, as well as chemotherapy-induced nausea/vomiting. ((Gyires & Zadori, 2016)
CBD1: Central cannabinoid receptors
“TheCB1 receptor is one of the most abundant G protein-coupled receptors (GPCRs) in the CNS and is found in particularly high levels in the neocortex, hippocampus, basal ganglia, cerebellum and brainstem.”(Kendall & Yudowski, 2016). The CBD-1 receptor binds the THC to mediate most of the CNS effects of it. CB1 receptors also act on 2-aracodonalglycerol (2 AG), which is found in breast milk and CNS as well as annandamines (AD) which is considered the “bliss molecule”. CBD1 receptors are restricted to presynaptic sites, which could indicate a possible role in local modulation of gene and protein expression after chronic receptor activation. CB1 receptors are indicated in many disorders that impact the CNS including several neurodegenerative disorders such as Huntington’s disease (HD), multiple sclerosis (MS) and Alzheimer’s disease (AD).” It’s expression is heterogeneous within the nervous system and is mainly responsible for cannabinoid psychoactive properties.”(McCoy, 2016)
CBD2: peripheral cannabinoid receptors
“The CB2 receptor exhibits a more defined pattern of expression in the brain than CB1 receptors, and is found predominantly in cells and tissues of the immune system.”(Kendall & Yudowski, 2016). They too act on 2AG and AD like CB1. However, in the CNS, CB2 receptor expression is associated with inflammation, particularly in the brain. “Unlike CB1 receptor-mediated cell activation, signal transduction through the CB2 receptor lacks psychotropic effect making it an attractive target for immunotherapy.”(McCoy, 2016)
A word about THC:
The cannabis plant contains more than 60 different active synthetic ligands for CBC1/2 with THC being the major psychoactive molecule among them. At the molecular level, THC acts as a partial agonist (promoter) of the CBD1 receptor. However, THC is not really required for the therapeutic mechanisms of CB1/CB2. Therefore in most over-the-counter products, such as Prime My Body CBD oil, the THC is <0.02%. Depending on the chemistry of the product and the bioavailability of the CBD’s, the THC is not required in high levels for the absorption of CBD.
A summary of what CBD does in your body:
Here is a summary of what CBD can do in your body. Keep in mind, exogenous CBD modulates the receptors; it does not attach directly on them or block them. It can pull up your own endogenous cannabinoid production and molecularly, it can modify gene transcription and stabilize neuroinflammation. For example, it can stabilize over-active glutamate receptors and stabilize activated microglia cells in the brain. In essence, CBD changes the way we create things in our brain. Other benefits of CBD include:
- Turning up genes like glutathione and superoxide dismutase
- Protein repair
- Turning down genes that are pro-inflammatory
- Lowering brain inflammation
CBD, INFLAMMATION AND IMMUNE SYSTEM
A fundamental characteristic of the immune system is the ability to distinguish friend and foe…..self and non-self-molecules or antigens. Inflammation is the innate immune response against infectious agents, and the inflammatory response promotes initiation of an adaptive immune response by antigen-specific T and B cells. When the immune system encounters a pathogen, innate immune cells recognize the pathogen via Toll-like receptors and other pattern-recognition receptors to trigger an inflammatory response. “Innate immune cells are an important source of endocannabinoids, and these cells synthesize and metabolize endocannabinoids.”(McCoy, 2016)
For many years, one puzzling aspect of innate immunity has been autoimmune conditions, which are due to inflammatory responses in the absence of an infection that contribute to tissue damage. Important innate immune cells express cannabinoid receptors, and cannabinoids influence their immune functions. For example cannabinoid studies involving toll-like receptors have concentrated in bacterial LPS responses via TLR4 as a classic model for inflammation. “For the most part, exogenous and endogenous cannabinoids interfere with proinflammatory cytokine and nitric oxide production by LPS or LPS stimulated monocytes, macrophages, microglia and macrophage cell lines in culture.”(McCoy, 2016) LPS is released from bacteria cells which are implicated in adrenal and HPA axis in individuals who have chronic bacterial infection. CBD oil can increase CB1 and CB2 receptor expression on peripheral blood monocytes, and “exogenous cannabinoids may alter the endocannabinoid system leading to greater suppression of the LPS response.”(McCoy, 2016) All this means is that using exogenous sources of CBD, such as found in CBD oil, can be used therapeutically to modulate inflammation and subsequent endocrine disruption caused by bacteria and modulate the immune system, which can be helpful in treating autoimmune diseases.
GASTROINTESTINAL ACTIONS OF CANNABINOIDS
There is evidence that activation or inhibition of peripheral and central cannabinoid receptors may influence the function of the GI tract. The existence of a functional endocannabinoid in the gut has been established – as CB1 and CB2 receptors are found in colonic tissue (Coutts and Izzo, 2004). The cannabinoid receptors, the endocannabinoids AEA and 2-AG, and proteins responsible for their synthesis and degradation are widely distributed in the GI tract and several data suggest that their expressions are substantially altered during inflammatory processes. (Gyires & Zadori, 2016) According to (DiPatrizio, 2016):
Evidence also suggests that dysregulation of the endocannabinoid system might play a role in intestinal disorders, including inﬂammatory bowel disease, irritable bowel syndrome, as well as obesity. There is evidence that the dyregulation can be expressed epigenetically. For example, single-nucleotide polymorphisms in genes for constituents of the endocannabinoid system—including fatty acid amide hydrolase (FAAH), the degradative enzyme for the endocannabinoid, anandamide, and cannabinoid type1receptor(CB1R)—are associated with increased colonic transport and irritable bowel syndrome.
In one study done on rats in 2016, it was seen that the released of non-cholinergic excitatory neurotransmitters may be regulated by CB1 receptors. CB1 and CB2 receptors and enzymes in regulating endocannabinoids can be modulated to protect the gastric mucosa against erosions, mucosal lesions and inflammation. “Activation of cannabinoid receptors by exogenous or endogenous ligands has been shown to decrease the formation of different types of experimental gastric ulcers.”(Gyires & Zadori, 2016) Acid secretion that occurs during NSAID-induced mucosal damage can also be inhibited via the CB1 receptors.
Another area that CBD’s are showing activation of the cannabinoid receptors in the gut that can suppress many of the inflammatory bowel related symptoms, such as diarrhea and visceral hypersensitivity. This is showing promise in modulating disease such as Chron’s disease and ulcerative colitis, both which are complex diseases involving altered intestinal flora that can induce mucosal disruption and result in penetration of luminal antigens into the gut wall. (Gyires & Zadori, 2016)
Below are some areas where there is a large body of evidence that cannabinoids exert on the GI Tract.
- Inhibition of inflammation. CBD can have both immunomodulatory and immunosuppressive effects. These effects are primarily mediated by CB2 receptors localized on macrophages and lymphocytes, but some studies underline the importance of CB1 receptors as well. Due to the complex anti-inflammatory action, cannabinoids can efficiently inhibit the development of colitis, as well as reduce the already established inflammation.
- Modulation of intestinal barrier functions-Epithelial damage and breach of the intestinal barrier are important factors in intestinal diseases and “leaky gut”, which allow bacterial products and other antigens to cross the epithelium and enter the lamina propria, resulting in inflammation and tissue damage. Restoration of the barrier function is an important approach in treating individuals with gut-related conditions. Although the data from various in vitro and in vivo studies are mixed, the anti-inflammatory properties of the cannabinoids can indirectly modify their action on intestinal permeability and improve barrier function. Alhamoruni, Larvin, and O’Sullivan (2012) looked specifically at the role cannabinoids had on intestinal permeability. T hey concluded that “locally produced endocannabinoids, acting via CB1 receptors play a role in mediating changes in permeability with inflammation, and that phytocannabinoids have therapeutic potential for reversing the disordered intestinal permeability associated with inflammation.” Alhamoruni, Larvin, and O’Sullivan’s (2012) study provides the suggestion that THC and/or CBD can/may (depending on your state) have a therapeutic role in healing IP and their research also provided evidence of a prophylactic role.
- Motility and Secretion-Beside their potent anti-inflammatory property and modulatory effect on intestinal epithelial permeability, cannabinoids also inhibit gastrointestinal motility and secretion, which both may alleviate diarrhea, a common clinical manifestation of IBD. They also have been shown to alleviate visceral hypersensitivity and abdominal pain. (Gyires & Zadori, 2016) Preclinical data suggest that cannabinoids may serve as useful tools for alleviating visceral hypersensitivity and relieving abdominal pain in IBD, and this assumption is supported by preliminary clinical studies, in which IBD-patients treated with cannabis reported a statistically significant pain reduction.
- Gut Microbiome-Several studies suggest the possibility of interactions between the endocannabinoid receptors and gut bacteria. Collectively, these studies underscore the ability for CB1R activation to control endothelial barrier integrity and provide novel evidence for interactions between the endocannabinoid system, gut microbiota, and possibly adiposity.
CBD AND CHRONIC PAIN
Chronic pain represents an emerging public health issue of massive proportions, particularly in view of aging populations in industrialized nations (Russo, 2008). Associated facts and figures are alarming: Responses to an ABC News poll in 2005 in the USA indicated that 19% of adults (38 million) have chronic pain. I am sure those numbers are even higher now. According to Russo, clinicians face difficulties managing intractable patients afflicted with cancer-associated pain, neuropathic pain, and central pain states (e.g., pain associated with multiple sclerosis) that are often inadequately treated with available opiates, antidepressants and anticonvulsant drugs. Therefore, the integration of cannabinoid medicines to the pharmacopoeia offers a novel approach to pain management. I wanted to summarize some of my findings on this topic in regards to pain management. When I searched on PubMed, there were many articles on this topic, so clearly there is quite a bit of research being conducted, but I decided to choose two of them that I felt was most appropriate.
Interesting their functions have been termed “relax, eat, sleep, forget, protect” (Russo, 2008). It demonstrates the ability to mediate the suppression of pain and inflammatory processes (Russo, 2008). Interestingly, a deficiency in endocannabinoid has been found in people suffering from conditions such as migraines, fibromyalgia and intestinal conditions such as IBS.
Below are some areas I bulleted that was particularly of interest in regards to ECS and pain management:
- Cannabinoids proved to be 10-fold more potent than morphine in wide dynamic range neurons mediating pain, through widespread action in areas of the thalamus (Russo, 2008).
- The ECS is active peripherally, where CBD1 stimulation reduces pain, inflammation, and hyperalgesia (Russo, 2008).
- Cannabinoid agonists produce many effects beyond those mediated directly on receptors, including anti-inflammatory effects and interactions with various other neurotransmitter systems (Russo, 2008).
- THC can increase serotonin. It affects widespread serotonergic systems, including its ability to decrease 5-hydroxytryptamine (5-HT) release from platelets, increasing its cerebral production and decreasing synaptosomal uptake (Russo, 2008).
- Cannabinoids pre-synaptically inhibit glutamate release. “The glutamatergic system is integral to development and maintenance of neuropathic pain, and is responsible for generating secondary and tertiary hyperalgesia in migraine and fibromyalgia via NMDA mechanisms” (Russo, 2008)
- THC produces 30%–40% reduction in NMDA responses, making THC a neuroprotective antioxidant (Russo, 2008).
- THC has been shown to stimulate beta-endorphin production by interacting with the endorphin/enkephalin system (Russo, 2008).
- Cannabidiol, inhibits glutamate neurotoxicity, and displays antioxidant activity greater than ascorbic acid (vitamin C) or tocopherol (vitamin E) (Russo, 2008).
- CBD is able to inhibit tumor necrosis factor-alpha (TNF-α) , as seen in a rodent model of rheumatoid arthritis (Russo, 2008).
- Cannabinoids suppress inflammatory and neuropathic pain by targeting a3 glycine receptors (Xiong et al., 2012)
- THC has twenty times the anti-inflammatory potency of aspirin and twice that of hydrocortisone. In contrast to all nonsteroidal anti-inflammatory drugs (NSAIDs), demonstrates no cyclo-oxygenase (COX) inhibition at physiological concentrations. “At a time when great concern is accruing in relation to NSAIDs in relation to COX-1 inhibition (gastrointestinal ulcers and bleeding) and COX-2 inhibition (myocardial infarction and cerebrovascular accidents), CBD, like THC, inhibits neither enzyme at pharmacologically relevant doses” (Russo, 2008).
Based on some of these facts from a small source of literature, I think there are opportunities for further research in the use of CBD supplements to determine if it can be used to complement any therapeutic healing protocol. I believe it has really helped me in many ways.
Alhamoruni, A., Wright, K., Larvin, M., & O’Sullivan, S. (2012). Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. British Journal of Pharmacology, 165(8), 2598–2610. http://doi.org/10.1111/j.1476-5381.2011.01589.x (Links to an external site.)
Coutts, A. A., & Izzo, A. A. (2004). The gastrointestinal pharmacology of cannabinoids: An update. Current Opinion in Pharmacology, 4(6), 572–579. https://doi.org/10.1016/j.coph.2004.05.007
DiPatrizio, N. V. (2016). Endocannabinoids in the Gut. Cannabis Cannabinoid Res, 1(1), 67-77. doi:10.1089/can.2016.0001
Gyires, K., & Zadori, Z. S. (2016). Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation. Curr Neuropharmacol, 14(8), 935-951.
Kendall, D. A., & Yudowski, G. A. (2016). Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease. Front Cell Neurosci, 10, 294. doi:10.3389/fncel.2016.00294
McCoy, K. L. (2016). Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation. Mediators Inflamm, 2016, 5831315. doi:10.1155/2016/5831315
Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag, 4(1), 245-259.
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S. R., Willenbring, D., . . . Zhang, L. (2012). Cannabinoids suppress inflammatory and neuropathic pain by targeting alpha3 glycine receptors. J Exp Med, 209(6), 1121-1134. doi:10.1084/jem.20120242
To purchase pH structured silver click here
I love to talk about things that are different than the conventional world.
I am here to talk about the benefits of Silver. As you know your body will heal itself if you give it the tools and silver is one of the tools that I use to give the body its ability to heal.
Silver destroys bacteria, yeast, mold and parasites. There is no antibiotic that can come close to that.
If you take 650 bacteria of bacteria that cause diseases and you put a broad spectrum bacteria like cipro,
And you put it in a petry dish, you know it only kills 22 out of the 650.
That’s pathetic? What happens to the other pathogens? Well, that is probably why you are here listening to this
This silver series is about Women’s issues. I have been following Dr. Gordon Pederson, the silver man. He is a naturophatic doctor with a PhD from the Toxicity program at Utah state. He is super knowledgeable and trust worthy.
He has education on silver and he particularly focuses on women. I have put a link below of his book below
I highly recommend you purchase it if you are interested in silver.
Why do I focus on women for this series? Well first, I am a woman.
Second, it is often an area that is overlooked in traditional medicine.
Silver is a women’s best friend. It destroys bacteria and yeast. It also destroys sexually transmitted diseases.
This blog series is a 3 part series on the benefits of silver relevant to women’s health. So let’s begin part 1.
The Need for Cleansing
Here is something that is not often discussed. The need for cleansing. Nobody talks about this. We clean our teeth. Some of us even do colon cleanses. But what nobody talks about is cleaning the female parts. The vaginal cavity is warm, moist cavity, and makes it the ideal place for the growth of bacteria, yeast and viruses. Problems can arise from poor hygiene, contamination, hormonal issues or genetics.
If you have pain, itchiness, foul odor, redness, swelling, cramps or abnormal bleeding, you have a problem. All of these situations respond to vaginal cleansing. Silver can destroy all the causes of vaginal problems whether it is bacterial, viral or fungal. The need for improved vaginal hygiene is evident when you research the sexually transmitted diseases, yeast infections and occurrence of viral infections that cause cancer of the uterus and cervix.
Structured Silver kills germs. These germs may be living in the pores (causing acne), in the vagina (causing a vaginal infection), in an eye (causing pinkeye), in the digestive tract (causing gas or a serious health problem), in a wound (obstructing healing or causing scarring), around a piercing (causing infection), on the cuticles (causing inflamed hangnails), on the lips (causing cold sores), in the bladder (causing bladder infection), on the toenails (causing odor or unsightly infections), etc.
Regardless of where they are growing, the problem is the same: germs are growing and disrupting your health.
If you can name an affected spot in or on your body and you can get silver into contact with germs that a growing there, that is where silver can help you.
If you keep silver in contact with the germs for six minutes, these germs will no longer be able to cause you health problems.
Silver IS the broad spectrum antimicrobial that:
Destroys pathogenic bacteria
Inhibits viral replication
Destroys many fungi, yeasts and protozoa
Structured Silver even kills antibiotic-resistant strains of bacteria such as MRSA.
Some bacterial infections no longer respond to any drugs and problem is getting worse. However, due to the fact that Structured Silver kills bacteria differently than traditional antibiotics, it kills resistant and non-resistant bacteria alike.
Structured silver is remarkably safe. It can be used internally in any orifice of the body-vagina, bladder,ears, eyes
If taken internally, it selectively kills pathogenic bacteria while leaving healthy bacteria (probiotics) unharmed. The way this selection happens is similar to the way probiotics are able to survive within the harsh environment of the stomach and digestive tract.
Additionally, silver is already being used in hospitals, space shuttles, washing machines, water filters and many other settings for its ability to control unwanted microbes.
Yet it is so safe and non-toxic that it would take a spill of over 12 million gallons of 10 ppm silver before the EPA would consider it a reportable spill.
Silver is great for prevention- as little as 2 tsp per day is recommended for general use. And yes, this includes UTI’s
Unlike conventional antibiotics, which are only available by prescription and are typically not recommended for long-term use, Structured Silver is able to combat pathogens without creating resistance.
Silver passes through the body unmetabolized- which we will talk about later.
The result is that Structured Silver is just as effective at disinfecting when it is leaving the body (killing the germs that cause bladder infections and urinary tract infections) as it was when it was swished in the mouth several hours earlier (killing the germs that cause gum disease, bad breath, cold sores, etc.)
In between drinking and excretion, it will have been equally effective while circulating through the bloodstream (killing pathogens wherever the blood flows) or traveling through the digestive tract (killing pathogens like E. coli or Salmonella a person may have swallowed at lunchtime.)
For women who experience frequent bladder and urinary tract infections, this is welcome news. As urine gathers in the bladder and is excreted, the same silver that eliminated germs throughout the body will disinfect these organs as well. In the next blog, I am going to talk about a very unique characteristic of silver
To purchase pH structured silver click here
To learn more about healing form IC naturally, please visit our website: https://ichealer.com If you are looking for self healing, we recently launched our Self Healing IC Course featuring 10 hours of video designed to help you discover your root cause. Once you know your root cause, you can start your healing journey. To find out more information about our exciting new course, please find the information below:
Here is the link to preview the course: https://ichealer.com/online-course/
Here is the Podia Course Page: https://ichealer.podia.com/course
The first module is totally FREE. You have nothing to lose and everything to gain. For more insightful videos on these burning topics, simply subscribe to this page so you can be notified of up to date information.